TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
KZR

Kezar Life Sciences Inc

Healthcare · Biotechnology

0.175$ +6.1% vs. previous close Closing price · As of: Aug 13, 2026

Ownership

Ownership Structure

Who owns Kezar Life Sciences Inc (KZR)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 69.9% of the shares are freely tradable; institutional investors hold 61.3%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 61.3%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 15.8%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 69.9%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 2.1%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 7Mio.

Largest Shareholders

Institutions

Institutions KZR
Name Stake (%) Shares Change (%) Date
Suvretta Capital Management, LLC 9.70 716,759 +0.0 03/31/2026
TANG CAPITAL MANAGEMENT LLC 8.99 664,314 +0.0 03/31/2026
Vanguard Capital Management, LLC 3.93 290,529 +0.0 03/31/2026
Affinity Asset Advisors, LLC 3.10 229,076 +0.0 03/31/2026
Renaissance Technologies Corp 2.55 188,426 +43.5 03/31/2026
Acadian Asset Management LLC 2.05 151,630 +0.0 03/31/2026
Ikarian Capital, LLC 1.38 102,211 +0.0 03/31/2026
BlackRock Inc 1.35 100,064 +1.4 03/31/2026
ADAR1 Capital Management LLC 1.11 81,933 -30.2 03/31/2026
Aldebaran Capital LLC 1.09 80,335 -0.4 03/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?